by Andrea Fenton Abbs | Jan 25, 2022 | ClinReg Strategy
Most leadership teams would agree that it is better to meet the timeline of a well-thought-out clinical study schedule than repeatedly miss the mark on an over-zealous one, even if the timeline is longer. No matter what your advisors told you, do not commit to your...
by Andrea Fenton Abbs | Dec 14, 2021 | BRIGHT Culture
We’re taking time to reflect on the blog topics we shared in 2021, the experience we gained, and the inspiring work we did to help clients strategize, design, and execute successful clinical studies to meet their goals. These achievements were all made possible by the...
by Andrea Fenton Abbs | Nov 9, 2021 | Study Execution
When a clinical study will be used to support an FDA market authorization application, it’s likely the agency will require a Bioresearch Monitoring (BIMO) inspection. Similar to our advice on clinical study design, it’s critical to “begin with the end in mind,”...
by Andrea Fenton Abbs | Oct 12, 2021 | Study Execution
It may seem counterintuitive that collecting too much data is a common pitfall in clinical study design. After all, clinical studies are labor-intensive, time-consuming, and expensive, so why wouldn’t you try to get everything you can out of your study? In this blog...
by Andrea Fenton Abbs | Mar 1, 2021 | BRIGHT Culture
Welcome to our new blog! I founded BRIGHT Research Partners in 2008 with the dream of creating a full-service clinical research organization that placed high value on beautiful deliverables, exceptional customer service, smart strategies, and a human-first philosophy...
